Sign In  |  Register  |  About Daly City  |  Contact Us

Daly City, CA
September 01, 2020 1:20pm
7-Day Forecast | Traffic

  • Search Hotels in Daly City

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Equillium Inc (NQ: EQ )

0.8300 -0.0310 (-3.60%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Equillium Inc

< Previous 1 2 3 4 5 6 Next >
EQ Stock Earnings: Equillium Beats EPS, Beats Revenue for Q4 2023
EQ stock results show that Equillium beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace
Equillium: Q4 Earnings Insights
Via Benzinga
Equillium Reports on Fourth Quarter and Full Year 2023 Financial Results and Corporate and Clinical Highlights
From Equillium, Inc.
Via Business Wire
Equillium to Present at the H.C. Wainwright Autoimmune & Inflammatory Disease Conference and the LD Micro Invitational Conference
From Equillium, Inc.
Via Business Wire
5 Stocks That More Than Doubled In February
U.S. stocks rallied in February, with the S&P 500 and the Nasdaq Composite Index recording the best month in nearly a decade. Meanwhile, the Dow 
Via Talk Markets
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Cognizant Technology Solutions To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Tuesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
Equillium Announces Update on Multi-Cytokine Inhibitors EQ101 & EQ102 in Development for Alopecia Areata and Celiac Disease
From Equillium, Inc.
Via Business Wire
Equillium Presents Positive Data from Phase 1b EQUALISE Study at the 2023 Annual Meeting of the American College of Rheumatology
From Equillium, Inc.
Via Business Wire
Equillium Reports Third Quarter 2023 Financial Results and Provides Corporate and Clinical Updates
From Equillium, Inc.
Via Business Wire
Equillium Announces Data from Phase 1b EQUALISE Study Presented at the 2023 Annual Meeting of the American Society of Nephrology
From Equillium, Inc.
Via Business Wire
10 Biotech Stocks Below Cash Value with Key Catalysts on the Horizon: An Analysis
Via ACCESSWIRE
Equillium Announces Abstracts Accepted for Presentation at the 2023 Annual Meetings of the American Society of Nephrology and the American College of Rheumatology
From Equillium
Via Business Wire
Equillium Announces Preclinical Data from New Orally Deliverable Multi-Cytokine Inhibitor in Presentation at the 18th Annual Peptide Therapeutics Symposium
From Equillium Inc.
Via Business Wire
Equillium to Host Analyst & Investor Day
From Equillium, Inc.
Via Business Wire
Equillium to Present at the JonesTrading 2023 Healthcare Summit
From Equillium, Inc.
Via Business Wire
Equillium to Present at the Cantor Fitzgerald Global Healthcare & LD Micro Main Event Conferences
From Equillium, Inc.
Via Business Wire
Equillium to Attend Wells Fargo Healthcare Conference & Present at H.C. Wainwright 25th Annual Global Investor Conference
From Equillium, Inc.
Via Business Wire
Equillium Reports Second Quarter 2023 Financial Results and Provides Corporate and Clinical Updates
From Equillium, Inc.
Via Business Wire
Why EVgo Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket
Gainers 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
We're starting off the day with a breakdown of all the biggest pre-market stock movers worth reading about on Thursday morning! 
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Equillium Announces $7.5 Million Share Repurchase Program
From Equillium, Inc.
Via Business Wire
Equillium to Present at the Jefferies Global Healthcare & LD Micro Invitational Conferences
From Equillium, Inc.
Via Business Wire
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Equillium Announces Poster Presentation at the Annual Meeting of The American Association of Immunologists
From Equillium, Inc.
Via Business Wire
Equillium Reports First Quarter 2023 Financial Results and Provides Clinical Updates
From Equillium, Inc.
Via Business Wire
Equillium Announces Poster Presentation at the Annual Meeting of the European Society for Blood and Marrow Transplantation
From Equillium, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 DalyCity.com & California Media Partners, LLC. All rights reserved.